Onc has very little competition..IV delivery Onc Pelareorep has very little competition.
why?
due to handling & delivery methods.
Pela is delivered systematically via I.V.
not inter tumour. The virus finds the cancer!
Only replicates in tumour cells.
That's why the safety profile is so good.
The most recent, co- therapy trials are in place to find the best fit ( efficacy) with a potential partner.
None of which would want to be rid of their important cancer drugs, but one that could improve their use or opportunities for use.